After finishing at $135.24 in the prior trading day, Universal Health Services Inc. (NYSE: UHS) closed at $126.93, down -6.14%. In other words, the price has decreased by -$8.31 from its previous closing price. On the day, 1123616 shares were traded. UHS stock price reached its highest trading level at $134.82 during the session, while it also had its lowest trading level at $126.78.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
Sponsored
Ratios:
Our goal is to gain a better understanding of UHS by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 81.73 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 111.41. For the most recent quarter (mrq), Quick Ratio is recorded 1.30 and its Current Ratio is at 1.40. In the meantime, Its Debt-to-Equity ratio is 0.80 whereas as Long-Term Debt/Eq ratio is at 0.78.
Upgrades & Downgrades
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 17 when McDonnell Eileen C. sold 1,680 shares for $134.64 per share. The transaction valued at 226,189 led to the insider holds 5,316 shares of the business.
FILTON STEVE sold 25,000 shares of UHS for $3,477,000 on May 11. The Executive Vice President & CFO now owns 93,800 shares after completing the transaction at $139.08 per share. On May 11, another insider, Nimetz Warren J., who serves as the Director of the company, sold 500 shares for $139.01 each. As a result, the insider received 69,507 and left with 2,256 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, UHS now has a Market Capitalization of 10.00B and an Enterprise Value of 15.17B. As of this moment, Universal’s Price-to-Earnings (P/E) ratio for their current fiscal year is 13.48, and their Forward P/E ratio for the next fiscal year is 11.20. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.25. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.66 while its Price-to-Book (P/B) ratio in mrq is 1.49. Its current Enterprise Value per Revenue stands at 1.12 whereas that against EBITDA is 9.41.
Stock Price History:
Over the past 52 weeks, UHS has reached a high of $154.65, while it has fallen to a 52-week low of $82.50. The 50-Day Moving Average of the stock is 133.34, while the 200-Day Moving Average is calculated to be 124.42.
Shares Statistics:
The stock has traded on average 704.04K shares per day over the past 3-months and 679.28k shares per day over the last 10 days, according to various share statistics. A total of 70.53M shares are outstanding, with a floating share count of 61.83M. Insiders hold about 1.70% of the company’s shares, while institutions hold 102.54% stake in the company. Shares short for UHS as of Apr 27, 2023 were 1.64M with a Short Ratio of 1.64M, compared to 1.88M on Mar 30, 2023. Therefore, it implies a Short% of Shares Outstanding of 2.35% and a Short% of Float of 3.58%.
Dividends & Splits
In the trailing 12 months, UHS’s forward annual dividend rate was 0.80, compared to 0.80 this year. Against a Trailing Annual Dividend Yield of 0.59%, it implies a Forward Annual Dividend Yield of 0.59%. The stock’s 5-year Average Dividend Yield is 0.46. The current Payout Ratio is 8.40% for UHS, which recently paid a dividend on Jun 14, 2023 with an ex-dividend date of May 30, 2023. Stock splits for the company last occurred on Dec 15, 2009 when the company split stock in a 2:1 ratio.
Earnings Estimates
Its stock is currently analyzed by 13 different market analysts. On average, analysts expect EPS of $2.42 for the current quarter, with a high estimate of $2.65 and a low estimate of $2.25, while EPS last year was $2.2. The consensus estimate for the next quarter is $2.5, with high estimates of $2.67 and low estimates of $2.33.
Analysts are recommending an EPS of between $10.7 and $9.78 for the fiscal current year, implying an average EPS of $10.17. EPS for the following year is $11.36, with 14 analysts recommending between $13.03 and $9.13.
Revenue Estimates
14 analysts predict $3.5B in revenue for the current quarter. It ranges from a high estimate of $3.55B to a low estimate of $3.45B. As of the current estimate, Universal Health Services Inc.’s year-ago sales were $3.32B, an estimated increase of 5.40% from the year-ago figure. For the next quarter, 14 analysts are estimating revenue of $3.53B, an increase of 7.40% over than the figure of $5.40% in the same quarter last year. There is a high estimate of $3.58B for the next quarter, whereas the lowest estimate is $3.46B.
A total of 16 analysts have provided revenue estimates for UHS’s current fiscal year. The highest revenue estimate was $14.23B, while the lowest revenue estimate was $14.02B, resulting in an average revenue estimate of $14.13B. In the same quarter a year ago, actual revenue was $13.4B, up 5.40% from the average estimate. Based on 16 analysts’ estimates, the company’s revenue will be $14.85B in the next fiscal year. The high estimate is $15.18B and the low estimate is $14.59B. The average revenue growth estimate for next year is up 5.10% from the average revenue estimate for this year.
